Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US8778924 | PRAGMA | Modified release amoxicillin products |
Dec, 2026
(2 years from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8357394 | PRAGMA | Compositions and methods for improved efficacy of penicillin-type antibiotics |
Dec, 2026
(2 years from now) | |
US8299052 | PRAGMA | Pharmaceutical compositions and methods for improved bacterial eradication |
May, 2027
(3 years from now) |
Market Authorisation Date: 23 January, 2008
Treatment: Use of once-a-day amoxicillin product to treat tonsillitis and/or pharyngitis secondary to streptococcus pyogenes; Method of treating tonsillitis and/or pharyngitis secondary to streptococcus pyogenes...
Dosage: TABLET, EXTENDED RELEASE;ORAL